Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention

This study aims to determine whether genetic variants that influence CYP3A4 expression are associated with platelet reactivity in clopidogrel-treated patients undergoing elective percutaneous coronary intervention (PCI), and to evaluate the influence of statin/fibrate co-medication on these associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergmeijer, Thomas O., Yasmina, Alfi, Vos, Gerrit J. A., Janssen, Paul W. A., Hackeng, Christian M., Kelder, Johannes C., Verma, Shefali S., Ritchie, Marylyn D., Gong, Li, Klein, Teri E., de Boer, Anthonius, Klungel, Olaf H., ten Berg, Jurriën M., Deneer, Vera H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564055/
https://www.ncbi.nlm.nih.gov/pubmed/32932966
http://dx.doi.org/10.3390/genes11091068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564055/
https://www.ncbi.nlm.nih.gov/pubmed/32932966
http://dx.doi.org/10.3390/genes11091068

Ejemplares similares